NIVF
NewGenIVF Group Ltd.
NASDAQ · Healthcare · Medical - Healthcare Plans · TH
$1.14
−5.00%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +1340.2%
- EBITDA
- +3532.4%
- EPS
- +8954.3%
Three-year CAGR
- Revenue
- -7.4%
- EBITDA
- +146.3%
- EBIT
- —
- Net income
- +178.2%
- EPS
- +112.6%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026